Syndeio Biosciences is a clinical-stage biotechnology company developing therapies to restore and enhance synaptic health in CNS disorders
Syndeio Biosciences is a clinical-stage biotechnology company developing therapies to restore and enhance synaptic health in CNS disorders. The company’s proprietary Boost™ Synapse Pharmacology Platform combines electrophysiology, behavior, and human neuronal network assays to predict clinical outcomes with unprecedented accuracy.